Financial reports
ARS
2023 FY
Annual report to shareholders
14 Jun 24
10-Q
2024 Q1
Quarterly report
2 May 24
10-K/A
2023 FY
Annual report (amended)
26 Apr 24
10-K
2023 FY
Annual report
28 Feb 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
ARS
2022 FY
Annual report to shareholders
16 Jun 23
10-Q
2023 Q1
Quarterly report
10 May 23
10-K
2022 FY
Annual report
1 Mar 23
Current reports
8-K
Departure of Directors or Certain Officers
31 May 24
8-K
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results
1 May 24
8-K
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results
28 Feb 24
8-K
Departure of Directors or Certain Officers
27 Feb 24
8-K
Jazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer
21 Feb 24
8-K
Entry into a Material Definitive Agreement
25 Jan 24
8-K
Results of Operations and Financial Condition
8 Jan 24
8-K
Departure of Directors or Certain Officers
15 Dec 23
8-K
Jazz Pharmaceuticals Announces Third Quarter 2023 Financial Results and Updates Financial Guidance
8 Nov 23
8-K
Departure of Directors or Certain Officers
12 Sep 23
Registration and prospectus
S-8
Registration of securities for employees
1 Mar 22
S-8
Registration of securities for employees
7 May 21
S-8
Registration of securities for employees
23 Feb 21
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Nov 20
S-8
Registration of securities for employees
2 Nov 20
S-8
Registration of securities for employees
25 Feb 20
S-8
Registration of securities for employees
26 Feb 19
S-8
Registration of securities for employees
9 May 18
8-A12B
Registration of securities on exchange
5 Apr 17
S-8
Registration of securities for employees
28 Feb 17
Proxies
DEFA14A
Additional proxy soliciting materials
14 Jun 24
DEF 14A
Definitive proxy
14 Jun 24
PRE 14A
Preliminary proxy
3 Jun 24
DEFA14A
Additional proxy soliciting materials
26 Jul 23
DEFA14A
Additional proxy soliciting materials
16 Jun 23
DEF 14A
Definitive proxy
16 Jun 23
PRE 14A
Preliminary proxy
6 Jun 23
DEFA14A
Additional proxy soliciting materials
22 Jul 22
DEFA14A
Additional proxy soliciting materials
15 Jul 22
DEFA14A
Additional proxy soliciting materials
7 Jul 22
Other
CT ORDER
Confidential treatment order
11 Jul 23
CT ORDER
Confidential treatment order
30 Jun 20
CT ORDER
Confidential treatment order
30 Jun 20
CT ORDER
Confidential treatment order
30 Mar 20
CT ORDER
Confidential treatment order
30 Mar 20
UPLOAD
Letter from SEC
20 Feb 20
CORRESP
Correspondence with SEC
14 Feb 20
CORRESP
Correspondence with SEC
17 Jan 20
CORRESP
Correspondence with SEC
20 Dec 19
CORRESP
Correspondence with SEC
19 Nov 19
Ownership
4
Patricia Carr
11 Jun 24
144
Notice of proposed sale of securities
7 Jun 24
4
Neena M Patil
7 May 24
144
Notice of proposed sale of securities
3 May 24
4
RENEE D GALA
9 Apr 24
4
Patricia Carr
8 Mar 24
4
RENEE D GALA
7 Mar 24
4
Samantha Pearce
7 Mar 24
4
Neena M Patil
7 Mar 24
4
Robert Iannone
7 Mar 24